Found 156 matching trials
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation PHASE1 The investigators propose a nonrandomized, Phase I study to assess the safe...
Show More Location
Hammersmith Hospital
Learn More & Join Trial
GKL-006Allo Injection in Patients With Advanced Solid Tumors PHASE1 This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinet...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer PHASE1 This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors PHASE1 This is a Phase 1 open-label, study designed to characterize the safety, to...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) PHASE1 This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Show More Location
Nkarta Investigational Site
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
FT576 in Subjects With Multiple Myeloma PHASE1 This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer PHASE1 The goal of this type of clinical trial study is to evaluate the safety and...
Show More Location
Anhui Cancer Hospital
Learn More & Join Trial
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia PHASE1 This is a phase I/II clinical trial using adoptive cell therapy with NK cel...
Show More Location
Hospital Universitario La Paz
Learn More & Join Trial
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) PHASE1 This study is for patients who have lymphoma or leukemia that has come back...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial